Home › Glioblastoma › Arizona
Glioblastoma clinical trials in Arizona
13 studies for Glioblastoma are looking for participants at sites in Arizona.
Cities in Arizona
Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
- Honor Health, Scottsdale
Recruiting
Ages 18 to 85 · All sexes · Updated Nov 12, 2026 · NCT06910306Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- HonorHealth Scottsdale Osborn Medical Center, Scottsdale
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07195591Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
- Mayo Clinic Hospital in Arizona, Phoenix
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT05432804Temozolomide, With or Without WSD0922-FU, for the Treatment of EGFR-Mutant, IDH-Wildtype Glioblastoma
- Mayo Clinic in Arizona, Scottsdale
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT07708961Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Mayo Clinic Scottsdale, Scottsdale
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 21, 2026 · NCT06810544SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Mayo Clinic - Arizona, Phoenix
- St. Joseph's Hospital and Medical Center, Phoenix
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT05303519A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions
- Chandler Regional Medical Center, Chandler
- St. Joseph's Hospital and Medical Center, Phoenix
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Oct 16, 2026 · NCT06072586Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
- Banner MD Anderson Cancer Center, Gilbert
- Arizona Cancer Center at UMC North/University Medical Center, Tucson
RecruitingPhase 1/2
Ages 18 to 99 · All sexes · Updated Oct 6, 2026 · NCT06814496BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors
- St. Joseph's Hospital and Medical Center, Phoenix
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT07485049Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
- Mayo Clinic in Arizona, Phoenix
Recruiting
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT07091864A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
- Mayo Clinic Hospital, Phoenix
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 14, 2026 · NCT07185880A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases
- St. Joseph's Hospital and Medical Center, Phoenix
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Mar 6, 2026 · NCT07268053SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Scottsdale
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.